Novel approaches for pharmacological management of atrial fibrillation.
about
Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillationPharmacologic management of arrhythmiasIn silico screening of the key cellular remodeling targets in chronic atrial fibrillationSmall-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities.A novel treatment strategy of new onset atrial fibrillation after cardiac surgery: an observational prospective study.Cardiac adrenergic control and atrial fibrillation.HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.Advances in the Pharmacological Treatment of Atrial Fibrillation.Fibroblast electrical remodeling in heart failure and potential effects on atrial fibrillationA new algorithm to diagnose atrial ectopic origin from multi lead ECG systems--insights from 3D virtual human atria and torso.The burden of atrial fibrillation in the Netherlands.3D virtual human atria: A computational platform for studying clinical atrial fibrillationCosts and clinical consequences of suboptimal atrial fibrillation management.Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes.The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysisAcute effects of intravenous dronedarone on electrocardiograms, hemodynamics and cardiac functions in anesthetized dogs.Effect of spironolactone on patients with atrial fibrillation and structural heart disease.New developments in atrial antiarrhythmic drug therapy.Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.Resveratrol and derivatives for the treatment of atrial fibrillation.Dronedarone in the management of atrial fibrillation.Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1.PA-6 inhibits inward rectifier currents carried by V93I and D172N gain-of-function KIR2.1 channels, but increases channel protein expression.[Basic mechanisms of the new antiarrhythmic drugs in atrial fibrillation].The Na+/K+ pump is an important modulator of refractoriness and rotor dynamics in human atrial tissue.In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics.A 2D Electromechanical Model of Human Atrial Tissue Using the Discrete Element MethodAtrial Fibrillation Dynamics and Ionic Block Effects in Six Heterogeneous Human 3D Virtual Atria with Distinct Repolarization Dynamics.Benchmarking electrophysiological models of human atrial myocytesVernakalant hydrochloride for the treatment of atrial fibrillation.Relationship between brain natriuretic peptide and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis.Irbesartan-mediated AT1 receptor blockade attenuates hyposmotic-induced enhancement of I Ks current and prevents shortening of action potential duration in atrial myocytes.I(KACh) at the whim of a capricious M2R.Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future ChallengesEfficacy of pentamidine analogue 6 in dogs with chronic atrial fibrillation
P2860
Q26995558-3247719B-4657-45B9-90CE-A792271BDEC7Q27014008-197B70C3-E1A2-4688-854D-08E19E34B403Q27322548-2C261D74-CDDE-4A1A-826A-4F29B8A20EC7Q33603023-82E4E7AB-CF12-44BF-81DD-F21AA049A9B5Q33712294-1387CEC2-29FF-4FB7-A90F-C33EACD3B017Q33792556-8B2F7EAB-82F9-41B4-B66B-431E956D768DQ33815633-94BC2037-E852-45BF-97F0-C7F189926CEAQ33916951-DBFB65DA-E54B-42E4-979E-9FDC50B9B9FCQ34383573-8624BBFC-16C5-465E-BA00-3DA6278C2C2CQ34561350-14DF2998-7912-4370-9D20-1EABDE85547EQ35001458-5ACC3563-3D59-4B36-B153-E802A99037E2Q35197116-14A8943B-803A-4BA1-AC85-3CA426F0596CQ35536198-9BCA8084-0B17-4511-A84E-EDA5A1C20F5DQ35885128-D0BE2349-CD45-410D-B035-2E8018147E4EQ36160619-559530BE-8B60-419A-913B-CF20ADAA0341Q36650575-C184BE8C-36CC-476F-A5F4-BD201CE89474Q36669824-3FF6FBAA-504C-405C-B394-0F6DC960FCC9Q36742906-00CB1D31-5DC9-400A-9286-CA2E0EF5928AQ37697498-6A0F75A2-58E1-4959-92AD-4CE0FDB95681Q37993754-EA6F5540-B5DA-4726-8BC5-B5AE8D01F6A8Q38553016-E818B85F-123C-4380-BCD8-A0DCFF7ED710Q38826285-05D84DD5-75D0-4AA4-8412-10107DA0917AQ39639701-ECE4723D-FFC4-43EA-8640-A9E4DCBEFBCBQ41033530-9FE7ED76-6BAE-41F3-8043-0E04BD4D1249Q41560451-75B19923-6573-4881-9302-28F9DB187056Q41968511-DDD4FF27-6F2D-4F90-B7AD-0E7C7F4D6E01Q42160738-A82F5400-EEA4-4B1F-8465-56B9B47C2B65Q42263914-0C92C6E0-EBF8-4033-BA97-CBEAA6CAD1C5Q42287521-901F5EA1-0D73-4F38-8A35-AC874F458CE6Q42568963-61115170-59C2-4CF0-89AC-09B1C8174180Q43235607-42CEBE9D-2A7F-41BA-8072-3DFEB0D63D52Q44416992-356EB2C4-6B79-466A-9803-FF61E81118F2Q45054461-372E3369-4F23-459E-8F62-DC4E0DA5BEA1Q45998449-3F6ED4B7-8FD4-4424-8196-C47AEA771FBDQ48644420-8DD8C623-09CE-44DC-BBE3-5945BDDD4CFBQ57161239-AF4DECD6-1B9B-4E8E-811E-935B666A849AQ58799919-174AE488-1A4A-4C6B-86D9-94AE27040BC0
P2860
Novel approaches for pharmacological management of atrial fibrillation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel approaches for pharmacological management of atrial fibrillation.
@en
Novel approaches for pharmacological management of atrial fibrillation.
@nl
type
label
Novel approaches for pharmacological management of atrial fibrillation.
@en
Novel approaches for pharmacological management of atrial fibrillation.
@nl
prefLabel
Novel approaches for pharmacological management of atrial fibrillation.
@en
Novel approaches for pharmacological management of atrial fibrillation.
@nl
P2860
P1433
P1476
Novel approaches for pharmacological management of atrial fibrillation
@en
P2093
Joachim R Ehrlich
P2860
P304
P356
10.2165/00003495-200969070-00001
P577
2009-01-01T00:00:00Z
P6179
1022243657